Fig. 3From: Predicting [177Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [68Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modelingIndividually observed concentrations (µg/L) of A [68Ga]Ga-HA-DOTATATE and B [177Lu]Lu-HA-DOTATATE in the spleen, kidney and tumors (stratified for patients 2 to 10)Back to article page